Aquestive Therapeutics (AQST) PT Lowered to $26 at Wedbush
Tweet
Share
E-mailGet Alerts AQST Hot Sheet
Price: $4.25 --0%
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wedbush analyst Liana Moussatos lowered the price target on Aquestive Therapeutics (NASDAQ: AQST) to $26.00 (from $28.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Aquestive reports study results for Anaphylm ahead of NDA resubmission
- Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
